S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains

Renalytix (RNLX) Earnings Date, Estimates & Call Transcripts

$0.83
+0.01 (+1.22%)
(As of 04/17/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Jun. 14Estimated
Actual EPS
(Feb. 14)
-$0.09
Consensus EPS
(Feb. 14)
-$0.09
Skip Charts & View Estimated and Actual Earnings Data

RNLX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RNLX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Renalytix Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241($0.12)($0.12)($0.12) 
Q2 20241($0.11)($0.11)($0.11) 
Q3 20241($0.10)($0.10)($0.10) 
Q4 20241($0.10)($0.10)($0.10) 
FY 20244($0.43)($0.43) ($0.43)

RNLX Earnings Date and Information

Renalytix last posted its earnings results on February 14th, 2024. The reported ($0.09) EPS for the quarter, meeting analysts' consensus estimates of ($0.09). The company had revenue of $0.71 million for the quarter, compared to analyst estimates of $0.70 million. Renalytix has generated ($0.45) earnings per share over the last year (($0.45) diluted earnings per share). Renalytix has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, June 14th, 2024 based off prior year's report dates.

Renalytix Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
6/14/2024
Estimated)
------- 
2/14/2024Q2 2024($0.09)($0.09)-($0.09)$0.70 million$0.71 million
11/14/2023Q3 2023($0.11)($0.11)-($0.11)$0.70 million$0.46 million    
9/28/2023Q4 2023($0.13)($0.10)+$0.03($0.09)$0.93 million$0.52 million
6/9/2023Q3 2023($0.13)($0.13)-($0.12)$0.73 million$0.72 million
3/30/2023Q2 2023($0.15)($0.14)+$0.01($0.14)$1.33 million$1.19 million    
11/30/2022Q1 2023($0.14)($0.14)-($0.12)$1.15 million$0.97 million    
10/31/2022Q4 2022-($0.22)($0.22)($0.22)-$0.83 million
6/30/2022Q3 2022($0.17)($0.20)($0.03)($0.20)$2.39 million$0.81 million
3/31/2022Q2 2022($0.17)($0.21)($0.04)($0.21)-$0.85 million
12/7/2021Q1 2022($0.14)($0.14)-($0.14)$2.25 million$0.48 million
10/21/2021Q4 2021-($0.08)($0.08)($0.08)-$0.47 million
6/15/2021Q3 2021($0.15)($0.12)+$0.03($0.12)$0.61 million$0.62 million

Renalytix Earnings - Frequently Asked Questions

When is Renalytix's earnings date?

Renalytix has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, June 14th, 2024 based off last year's report dates. Learn more on RNLX's earnings history.

Did Renalytix beat their earnings estimates last quarter?

In the previous quarter, Renalytix (NASDAQ:RNLX) reported ($0.09) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.09). Learn more on analysts' earnings estimate vs. RNLX's actual earnings.

How much revenue does Renalytix generate each year?

Renalytix (NASDAQ:RNLX) has a recorded annual revenue of $3.40 million.

How much profit does Renalytix generate each year?

Renalytix (NASDAQ:RNLX) has a recorded net income of -$45.61 million. RNLX has generated -$0.45 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NASDAQ:RNLX) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners